<h4>Background</h4>Hypomagnesemia is one of the characteristic side effects of the human anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, cetuximab and panitumumab. Here, EGFR is linked to familial primary hypomagnesemia.